Heather Quist
Nurse Practitioner · O Fallon, MONPI 1861888729
Payments from drug & device makers
Across 215 payments — averaging $19.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$802
- Novo Nordisk$650
- Lilly USA, LLC$414
- Pfizer$369
- Boehringer Ingelheim$182
- GSK$172
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,280100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $802 |
| Novo Nordisk | 31 | $650 |
| Lilly USA, LLC | 21 | $414 |
| Pfizer | 28 | $369 |
| Boehringer Ingelheim | 9 | $182 |
| GSK | 10 | $172 |
| Teleflex LLC | 1 | $154 |
| AstraZeneca(2 entities) | 8 | $121 |
| Neurocrine Biosciences, Inc. | 1 | $118 |
| Abbott | 6 | $106 |
| Lundbeck LLC | 4 | $105 |
| Exact Sciences | 5 | $100 |
| Axsome Therapeutics, Inc. | 5 | $98 |
| Johnson & Johnson | 3 | $86 |
| Otsuka America Pharmaceutical, Inc. | 5 | $83 |
| Medtronic | 3 | $79 |
| Amgen | 4 | $78 |
| Merck | 3 | $56 |
| Dexcom, Inc. | 2 | $53 |
| Idorsia Pharmaceuticals US Inc | 3 | $40 |
| Corium, LLC | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Seqirus USA Inc | 1 | $36 |
| Bayer | 2 | $33 |
| Tris Pharma Inc | 2 | $33 |
| Nevro Corp. | 1 | $26 |
| Radius Health, Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $25 |
| Edwards Lifesciences | 1 | $24 |
| Itamar Medical Inc | 1 | $23 |
| Neos Therapeutics, LP | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $15 |
| Globus Medical | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,280 in reported general payments places this provider in the 90th percentile of 1,898 nurse practitioner providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 37 | $43,449 |
| MounjaroTirzepatide | 24 | $25,501 |
| JardianceEmpagliflozin | 14 | $24,061 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $5,718 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 11 | $5,034 |
| SynthroidLevothyroxine Sodium | 16 | $821 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $590 |
| Bupropion XlBupropion Hcl | 28 | $588 |
| Atorvastatin Calcium | 80 | $587 |
| Gabapentin | 16 | $511 |
| Losartan Potassium | 37 | $403 |
| Amlodipine Besylate | 65 | $399 |
| Levothyroxine Sodium | 68 | $366 |
| Pantoprazole Sodium | 55 | $328 |
| Trazodone Hcl | 26 | $298 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $650 | $43,44937 claims |
| Lilly USA, LLCMounjaro | $414 | $25,50124 claims |
| Boehringer IngelheimJardiance | $182 | $24,06114 claims |
| MerckJanumet Xr | $56 | $5,03411 claims |
| AbbVieSynthroid | $802 | $82116 claims |
| Almatica Pharma LLCSertraline Hcl | $15 | $12820 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,898 nurse practitioner providers in Missouri.
Other nurse practitioner in O Fallon
- Jennifer PhillipsO Fallon$15K
- Aeron SheffieldChesterfield$269K
- Rachel ImperatoOsage Beach$260K
- Matthew BrunsBridgeton$126K
- Michelle DickensSpringfield$59K
- Robert HafnerKansas City$47K
- Tracey CarpenterChesterfield$47K
- Laura GrantSaint Charles$34K
- Courtney JefferyKansas City$24K
- Carrie Roth BettlachSaint Louis$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.